Development of a Diagnostic Biosensor Method of Hypersensitivity Pneumonitis towards a Point-of-Care Biosensor
Tatiana Fiordelisio,
Ivette Buendia-Roldan,
Mathieu Hautefeuille,
Diana Del-Rio,
Diana G. Ríos-López,
Diego Zamarrón-Hernández,
Samuel Amat-Shapiro,
Andrea Campa-Higareda,
Edgar Jiménez-Díaz,
Erika González-Villa,
Janikua Nelson-Mora,
Natllely García-Carreño,
Jehú López-Aparicio,
Eduardo Montes,
Armando Santiago-Ruiz,
Annie Pardo,
Moisés Selman
Affiliations
Tatiana Fiordelisio
Departamento de Biología, Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Ivette Buendia-Roldan
Instituto Nacional de Enfermedades Respiratorias Dr. Ismael Cosio Villegas, Mexico City 14080, Mexico
Mathieu Hautefeuille
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Diana Del-Rio
Departamento de Biología, Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Diana G. Ríos-López
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Diego Zamarrón-Hernández
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Samuel Amat-Shapiro
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Andrea Campa-Higareda
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Edgar Jiménez-Díaz
Departamento de Biología, Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Erika González-Villa
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Janikua Nelson-Mora
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Natllely García-Carreño
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Jehú López-Aparicio
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Eduardo Montes
Instituto Nacional de Enfermedades Respiratorias Dr. Ismael Cosio Villegas, Mexico City 14080, Mexico
Armando Santiago-Ruiz
Instituto Nacional de Enfermedades Respiratorias Dr. Ismael Cosio Villegas, Mexico City 14080, Mexico
Annie Pardo
Departamento de Biología, Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Moisés Selman
Laboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia LANSBioDyT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
In spite of a current increasing trend in the development of miniaturized, standalone point-of-care (PoC) biosensing platforms in the literature, the actual implementation of such systems in the field is far from being a reality although deeply needed. In the particular case of the population screenings for local or regional diseases related to specific pathogens, the diagnosis of the presence of specific antibodies could drastically modify therapies and even the organization of public policies. The aim of this work was to develop a fast, cost-effective detection method based on the manipulation of functionalized magnetic beads for an efficient diagnosis of hypersensitivity pneumonitis (HP), looking for the presence of anti-pigeon antigen antibodies (APAA) in a patient’s serum. We presented a Diagnostic Biosensor Method (DBM) in detail, with validation by comparison with a traditional high-throughput platform (ELISA assay). We also demonstrated that it was compatible with a microfluidic chip that could be eventually incorporated into a PoC for easy and broad deployment using portable optical detectors. After standardization of the different reaction steps, we constructed and validated a plastic chip that could easily be scaled to high-volume manufacturing in the future. The solution proved comparable to conventional ELISA assays traditionally performed by the clinicians in their laboratory and should be compatible with other antibody detection directly from patient samples.